Spyre Therapeutics, Inc. Quarterly Return On Equity in % from Q3 2016 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Spyre Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from Q3 2016 to Q2 2024.
  • Spyre Therapeutics, Inc. Return On Equity for the quarter ending June 30, 2024 was -160 %, a 108% decline year-over-year.
  • Spyre Therapeutics, Inc. annual Return On Equity for 2023 was 576 %.
  • Spyre Therapeutics, Inc. annual Return On Equity for 2022 was -127 %, a 107% decline from 2021.
  • Spyre Therapeutics, Inc. annual Return On Equity for 2021 was -61.4 %, a 10.6% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -160 -2.11K -108% Apr 1, 2024 Jun 30, 2024
Q1 2024 1.25K +1.38K Jan 1, 2024 Mar 31, 2024
Q4 2023 576 +704 Oct 1, 2023 Dec 31, 2023
Q3 2023 319 +434 Jul 1, 2023 Sep 30, 2023
Q2 2023 1.95K +2.06K Apr 1, 2023 Jun 30, 2023
Q1 2023 -132 -53.5 -68.1% Jan 1, 2023 Mar 31, 2023
Q4 2022 -127 -65.8 -107% Oct 1, 2022 Dec 31, 2022
Q3 2022 -115 -58.8 -105% Jul 1, 2022 Sep 30, 2022
Q2 2022 -105 -54.8 -108% Apr 1, 2022 Jun 30, 2022
Q1 2022 -78.6 -20.3 -34.9% Jan 1, 2022 Mar 31, 2022
Q4 2021 -61.4 +7.29 +10.6% Oct 1, 2021 Dec 31, 2021
Q3 2021 -56.2 +25.3 +31% Jul 1, 2021 Sep 30, 2021
Q2 2021 -50.7 +48.7 +49% Apr 1, 2021 Jun 30, 2021
Q1 2021 -58.2 +54.9 +48.5% Jan 1, 2021 Mar 31, 2021
Q4 2020 -68.7 +19.3 +21.9% Oct 1, 2020 Dec 31, 2020
Q3 2020 -81.4 -2.49 -3.16% Jul 1, 2020 Sep 30, 2020
Q2 2020 -99.4 -27.9 -39.1% Apr 1, 2020 Jun 30, 2020
Q1 2020 -113 -46.5 -69.9% Jan 1, 2020 Mar 31, 2020
Q4 2019 -88 -16.6 -23.2% Oct 1, 2019 Dec 31, 2019
Q3 2019 -78.9 -16.8 -27.1% Jul 1, 2019 Sep 30, 2019
Q2 2019 -71.5 -14.3 -25.1% Apr 1, 2019 Jun 30, 2019
Q1 2019 -66.6 -11.7 -21.4% Jan 1, 2019 Mar 31, 2019
Q4 2018 -71.4 -23.1 -47.9% Oct 1, 2018 Dec 31, 2018
Q3 2018 -62.1 -18.1 -41% Jul 1, 2018 Sep 30, 2018
Q2 2018 -57.2 -17.9 -45.8% Apr 1, 2018 Jun 30, 2018
Q1 2018 -54.8 -19.1 -53.6% Jan 1, 2018 Mar 31, 2018
Q4 2017 -48.3 +0.35 +0.72% Oct 1, 2017 Dec 31, 2017
Q3 2017 -44.1 +42.6 +49.1% Jul 1, 2017 Sep 30, 2017
Q2 2017 -39.2 Apr 1, 2017 Jun 30, 2017
Q1 2017 -35.7 Jan 1, 2017 Mar 31, 2017
Q4 2016 -48.6 Oct 1, 2016 Dec 31, 2016
Q3 2016 -86.6 Jul 1, 2016 Sep 30, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.